MedTrace Logo

Post-Approval Clinical Study of the Talent Thoracic Stent Graft to Treat Thoracic Aortic Aneurysms (THRIVE)

NCT00805948 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 349

Last updated 2021-09-27

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the long-term safety and effectiveness of the Talent Thoracic Stent Graft System for treatment of descending thoracic aneurysms (DTA)following U.S. market approval.

Conditions

  • Thoracic Aortic Aneurysms

Interventions

DEVICE

Talent Thoracic Stent Graft System

endovascular repair of descending thoracic aortic aneurysms using the Talent Thoracic Stent Graft System.

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Medtronic Cardiovascular

    lead INDUSTRY

Principal Investigators

  • Adam W Beck, MD · University of Florida

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2016-08-31
Completion
2017-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00805948 on ClinicalTrials.gov